In a new series for MS Money Moves Premium Members, Chris Stang a PharmD candidate at the University of Findlay and Nationwide Pharmacy Intern will evaluate a few pieces of data releases from health … [Read more...] about Eye-Catching Results at AACR 2019: A Quick Road Map
ficlatuzumab
Evaluating the Merits of AVEO’s Potential Purchase
At the end of January, the small-cap biotechnology company AVEO Oncology (AVEO) updated investors on the delayed timeline for filing with FDA for their lead compound tivozanib. This news led to a … [Read more...] about Evaluating the Merits of AVEO’s Potential Purchase
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.